- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
(AAO) Applying impact of real-world data on day-to-day practice
Ted Leng, MD, MS, Byers Eye Institute at Stanford, and medical advisor for Verana Health, talks about data insights for retinal surgeons. Steven D. Schwartz, MD, Stein Eye Institute, UCLA, highlights his AAO presentation, “New Insight into Real-World U.S. Injection Data."
Ted Leng, MD, MS, associate professor of ophthalmology with the Byers Eye Institute at Stanford, and medical advisor for Verana Health, talks about data insights for retinal surgeons. Leng is joined by Steven D. Schwartz, MD, the Ahmanson Professor of Ophthalmology and chief-retina division with Stein Eye Institute, UCLA. Schwartz highlights his AAO presentation, “New Insight into Real-World U.S. Injection Data,” which highlights the impact of the coronavirus disease 2019 pandemic on intravitreal injection usage.
